EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

A Case Series of Raynaud’s Phenomenon in the Setting of Immune Checkpoint Inhibitors

Yuanteng Jeff Li iD, Maryam Buni, Jean H Tayar, Huifang Lu, Michael Davies, Carl Michael Gay, Yasir Elamin, Ryan Huey, Eric Jonasch, Shervin Assassi

Journal of Immunotherapy and Precision Oncology · 25.09.2026 · 9 (4) · 141-146

DOI: 10.36401/jipo-26-3 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Immunotherapy and Precision Oncology, erschienen am 25.09.2026. Verfasst von Yuanteng Jeff Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Rheumatology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston TX, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although immune checkpoint inhibitors (ICIs) have improved oncological outcomes, they can cause a myriad of inflammatory conditions known as immune-related adverse events (irAEs). Raynaud’s phenomenon (RP) is a rare rheumatologic irAE that may arise de novo or present as an exacerbation of preexisting disease. This case series aims to describe ICI-induced RP in patients without a rheumatological diagnosis seen at a large, specialized cancer center. Our case series describes five patients with ICI-induced RP who were evaluated by rheumatology at a cancer center during the past 3 years where their cancers, type of ICIs, diagnostic tests, and treatments are discussed in detail. Among our five patients, one patient had preexisting psoriatic arthritis, and one had preexisting RP. The outcome of our patients’ ICI-induced RP varied widely. Although three patients had significant digital ischemia resulting in ulceration requiring epoprostenol infusions, the remaining two patients had mild digital ischemia that were controlled conservatively. However, none of our patients had clinical features to suggest systemic sclerosis (SSc), where RP is often the first symptom. Interestingly, interferon-γ and interleukin-6 were the most frequently elevated cytokines when checked in these patients. This is the first case series, to the authors’ knowledge, to describe ICI-induced RP, which may occur without other clinical features of an autoimmune rheumatological disease. The severity of the disease may vary, but it warrants increased awareness and prompt initiation of appropriate treatment.

Schlagwörter

Stichwörter der Autor:innen

Raynaud’s phenomenonimmune-related adverse eventsimmunotherapysystemic sclerosis

Autor:innen und Institutionen

  • Section of Rheumatology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston TX, USA.
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX, USA.
  • Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX, USA.
  • Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX, USA.
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX, USA.
  • Division of Rheumatology, Department of Internal Medicine, UTHealth Houston, Houston TX, USA.

ORCID-Profile: Yuanteng Jeff Li

Zitieren

APA

Li, Y. J., Buni, M., Tayar, J. H., Lu, H., Davies, M., Gay, C. M., Elamin, Y., Huey, R., Jonasch, E., & Assassi, S. (2026). A Case Series of Raynaud’s Phenomenon in the Setting of Immune Checkpoint Inhibitors. Journal of Immunotherapy and Precision Oncology, 9(4), 141-146. https://doi.org/10.36401/jipo-26-3

Vancouver

Li YJ, Buni M, Tayar JH, Lu H, Davies M, Gay CM, et al. A Case Series of Raynaud’s Phenomenon in the Setting of Immune Checkpoint Inhibitors. Journal of Immunotherapy and Precision Oncology. 2026;9(4):141-146. doi:10.36401/jipo-26-3

BibTeX
@article{Li2026,
  author = {Li, Yuanteng Jeff and Buni, Maryam and Tayar, Jean H and Lu, Huifang and Davies, Michael and Gay, Carl Michael and Elamin, Yasir and Huey, Ryan and Jonasch, Eric and Assassi, Shervin},
  title = {A Case Series of Raynaud’s Phenomenon in the Setting of Immune Checkpoint Inhibitors},
  journal = {Journal of Immunotherapy and Precision Oncology},
  year = {2026},
  volume = {9},
  number = {4},
  pages = {141--146},
  doi = {10.36401/jipo-26-3}
}
Kostenlos starten →